Pegasus Wins ‘Consultancy of the Year’ at Communiqué Awards 2014
July 9, 2014 |
Pegasus, the UK’s leading independent health communications consultancy, picked up the much coveted ‘Consultancy of the Year’ award at last week’s Communiqué Awards 2014, fighting off stiff competition from the health industry.
Pegasus Wins ‘Consultancy of the Year’ at Communiqué Awards 2014 The accolades continue as Pegasus scoops two award’s at Communiqué
Pegasus, the UK’s leading independent health communications consultancy, picked up the much coveted ‘Consultancy of the Year’ award at last week’s Communiqué Awards 2014,fighting off stiff competition from the health industry. The award is further confirmation that the consultancy continues to go from strength to strength, creating outstanding integrated campaigns whilst remaining focused on delivering outcomes that truly inspire healthy decisions.
In addition to the consultancy win, Pegasus was also highly commended for ‘Excellence in Digital Communications’ for its work on the Bio-Oil ‘Skin Stories’ campaign. The prestigious Communiquè Awards recognise excellence in healthcare communications to local, European and international audiences, acting as a benchmark for the highest possible standards across the industry.
Pegasus went through a rigorous judging process from industry experts and stakeholders to be finally crowned the overall consultancy winner. The Communique judges said of the win: “We chose Pegasus because they did everything so well. They were authentic, really focused on forming great client relationships and really driving the change in behaviour that would deliver the objectives that their clients want.”
Jo Spadaccino, Director and Head of Pharma & Life Sciences at Pegasus, commented: “We’re absolutely delighted to have won such a revered award. For us it signals that our overall approach as a consultancy is one that is resonating with the demands of today’s complex health market, but also of course that our hard work is resulting in success – for us, our clients and ultimately for the healthy decisions we aim to inspire amongst a diverse set of stakeholders. It has to be said though, we take the responsibility to deliver against this accolade very seriously and will be continuing to respond to our customers’ needs and innovate as needed to stay at the top of the game!”
ENDS
For more information please contact Maria Boiling or Lesley Fitzpatrick-Feurstein at Pegasus on 01273 712000 or mboiling@thisispegasus.co.uk / lfitzpatrick-feurstein@thisispegasus.co.uk
Notes to editors
Located in Brighton with a 70-strong team of communications experts, Pegasus specialises in helping the public and private sector communicate healthy messages through integrated communications programmes. Focusing on an overall mission to ‘Inspire Healthy Decisions’ and driven by a health first, sector second approach, Pegasus has a demonstrative track record of creating and implementing campaigns that inspire change.
The Pegasus approach to planning starts by investing time understanding the varied nature of decisions in every area of people’s day to day lives, from the general public through to the healthcare professionals that treat and the policy makers that shape the environment in which they work. The consultancy’s fully integrated approach blends unrivalled health contacts across the international, national, consumer, regional and specialist press, with in-house corporate, creative, social and digital services.
Pegasus’s clients currently include GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil, Danone, Homedics, Novo Nordisk and Pierre Fabre.
For more information please visit www.thisispegasus.co.uk.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Infographic: Are data blind spots putting your launch at risk?
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…
Key takeaways from ASCO® 2026
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…
Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the…
Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact
Discover how AI, analytics and real-world data are reshaping Medical Affairs.
How did multifaceted support from across Inizio help a biotech firm prepare for launch?
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.
Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency
Explore Inizio Medical’s key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.